Sandoz Keeps Tabs On Teva Skinny Label Ruling

As Q3 Sales Reveal ‘Two Sides’ To Sandoz

 
• By Dean Rudge
  
Man holding binoculars
"We’re watching the progression now with Teva going to appeal," Sandoz underlined. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin